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Insulin-like growth factor-I restores microvascular autoregula-
tion in experimental chronic renal failure. Impairment of auto-
regulation (AR) is associated with accelerated progression of
chronic renal failure (CRF). As the bioavailability of insulin-like
growth factor-I (IGF-I) is low in CRF, we investigated the effects
of acute luminal application of 10 nM recombinant human IGF-I
on AR in juxtamedullary (JM) afferent arterioles (AA) perfused
in vitro with a blood solution [(;30% hematocrit (HCT)]. Studies
were conducted in AA from adult male rats three to four weeks
after five-sixths nephrectomy (Nx) by either surgical excision (N 5
7) or infarction (N 5 5) of two thirds of the remnant kidney;
controls (N 5 6) had sham surgery. AA from both Nx groups
exhibited marked hypertrophy and impaired AR responses (60 to
140 mm Hg perfusion pressure), features more pronounced in the
infarction group. Responses to abluminal acetylcholine (10 mM)
were similar in sham and excision groups but were significantly
blunted in the infarction group. All groups vasodilated signifi-
cantly after Ca-channel blockade (10 mM MnCl2). IGF-I restored
AR in AA from both Nx groups (P , 0.05, analysis of variance)
while it vasodilated AA from controls. These results suggest that
IGF-I may protect the glomerulus from injury by maintaining
autoregulatory control of renal blood flow, thereby slowing the
progression of CRF.
Injury to the glomerulus by elevated intravascular pres-
sures and flows is thought to play a major role in the
pathogenesis of chronic renal failure (CRF) [1]. In rat
models of CRF, progressive loss of renal function and
glomerular sclerosis are accelerated by hypertension and
impairment of renal blood flow autoregulation (AR) [2, 3].
Another complication in CRF is a reduction in the biolog-
ical activity of insulin-like growth factor-I (IGF-I), as
commonly manifested by reduced longitudinal growth [4].
In the rat, this appears to be related to increased hepatic
production of IGF-I–binding proteins [4], as well as de-
creased renal clearance of IGF-I binding proteins and
fragments. Excess IGF binding proteins sequester IGF-I,
thereby limiting its binding to the IGF-I receptor ([5] has a
comprehensive review).
In addition to its effects on metabolism and growth,
IGF-I has significant vascular activity. In healthy humans
and rats, IGF-I vasodilates the renal vasculature and in-
creases glomerular filtration rate [6, 7], and IGF-I has been
proposed for therapeutic use in CRF [8]. In this study, we
investigated the effects of acute IGF-I treatment on the
reactivity of juxtamedullary (JM) afferent arterioles (AA)
from rats with experimental CRF. The objectives were to
determine if direct investigation of renal microvascular
function is feasible in remnant kidneys and to compare the
effects of IGF-I on AR in JM AA from normal and CRF
rats.
METHODS
Experimental CRF was induced in adult male Sprague-
Dawley rats (;200 g body weight) by five-sixths nephrec-
tomy (Nx) under sodium pentobarbital anesthesia (50
mg/kg). As the method of renal mass reduction in the
remnant kidney has been shown to influence the progres-
sion of CRF in rats [9], two thirds of the cortical mass of the
left kidney was ablated, following decapsulation to preserve
the adrenal glands, via either surgical excision of both poles
or infarction of both poles by ligation of renal artery
branches. The right kidney was removed. Controls under-
went sham surgery. Experiments were conducted three to
four weeks after Nx using the blood-perfused JM nephron
technique developed by Casellas and Navar [10]. Following
anesthesia (110 mg/kg Inactin), the left kidney was cleared
via an aortic catheter, removed, and dissected to expose the
perihilar cortex. Major arteries supplying the rest of the
kidney were ligated. During dissection, the kidney was
perfused with a gassed Krebs-bicarbonate-Ringer (KBR)
solution containing 4% albumin. During measurements,
the kidney was perfused with a blood solution prepared
from fresh, washed red blood cells (collected from nonure-
mic donor rats) and resuspended in KBR-6% albumin
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solution to a hematocrit of ;30%. The preparation was
superfused with warmed (37°C) KBR solution with 1%
albumin. The reactivity of the mid-AA segments was as-
sessed using videomicroscopy to measure changes in lumen
diameter. Recombinant human IGF-I (10 nM; Genentech)
was applied luminally. Acetylcholine (10 mM; Sigma) was
applied abluminally to verify basic functionality of the
endothelial nitric oxide (NO) system. At the end of the
studies, 10 mM MnCl2 was applied abluminally to deter-
mine relaxed vessel diameter. Statistical analysis was by
one- or two-way analysis of variance (ANOVA), based on
repeated measures (RM) where appropriate, followed by
Student-Newman-Keuls multiple comparison tests; P ,
0.05 was considered significant.
RESULTS AND DISCUSSION
Figure 1 shows a perfused JM nephron from a uremic rat
three weeks after five-sixths Nx by surgical excision. Hyper-
trophy of the vessels in the remnant kidney is evident in the
large diameters of the afferent and efferent arterioles. The
macula densa region, including individual cells, is also
clearly visible. Figure 2 summarizes the results of the AR
studies in mid-AA segments. In comparison to the controls,
basal AA diameters were significantly larger in both Nx
groups, with the largest diameters seen in the infarction
group (two-way ANOVA). This pattern was also evident
following Ca channel blockade, which resulted in signifi-
cant pressure-dependent vasodilation in all groups (two-
way RM ANOVA). This indicates that vasodilatory reserve
is not substantially reduced in JM AA in remnant kidneys
when perfused in vitro.
AR responsiveness was attenuated in both CRF groups.
In the excision group, this was evident between 100 and 140
mm Hg, whereas in the infarction group, AA diameter was
unchanged over the entire pressure range studied. In
control AA, application of 10 nM IGF-I significantly shifted
the autoregulation curve upward (two-way RM ANOVA),
and autoregulatory responsiveness was significantly en-
hanced (comparison before and after IGF-I of diameter
change between 60 and 140 mm Hg; paired t-test). In both
groups of CRF rats, IGF-I significantly enhanced autoreg-
ulatory responsiveness (two-way RM ANOVA). In the
excision group, this resulted in a significant vasodilation at
60 mm Hg and vasoconstriction at 140 mm Hg (RM
ANOVA). In the infarction group, IGF-I caused significant
vasoconstriction at 100 and 140 mm Hg (RM ANOVA).
Figure 3 illustrates the responses to abluminal applica-
tion of 10 mM acetylcholine. The vasodilatory responses
were similar in the control and excision groups, suggesting
that the endothelial NO system is functional in this model
of CRF. In contrast, the responses in AA from rats
subjected to renal infarction were blunted significantly
(ANOVA).
This study demonstrates the feasibility of direct study of
the JM microvasculature in rat models of CRF. As abnor-
malities in intravascular pressures and flows play a major
role in the pathogenesis of CRF, our techniques provide
unique insight into the pathophysiology of intact AAs in
remnant kidneys. The principle results show that AR ability
is impaired in JM AA in remnant kidneys, that AR can be
at least partly restored by acute IGF-I treatment, and that
the method of five-sixths Nx can significantly influence the
functional state of JM AA.
The impairment of AR responsiveness in JM AA from
CRF kidneys is consistent with other studies in intact rats:
Bidani et al have demonstrated impaired AR in conscious
Fig. 1. A perfused juxtamedullary nephron in a remnant kidney reduced by surgical excision. Visible are an afferent arteriole (A), efferent arteriole
(E), glomerulus (G), and macula densa (M). The image is a composite of overlapping video fields. The bar in the upper left is 25 mm.
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five-sixths Nx rats and have found a strong association
between systemic hypertension and the progression of
glomerular sclerosis [2, 3, 11]. This agreement suggests that
the behavior of JM AA parallels that in more superficial
nephrons. Although the mechanism of AR dysfunction in
CRF was not addressed in this study, our results do
demonstrate that it is not dependent on the presence of
uremic blood. Our results also show that the method of
five-sixths Nx can have substantial impact on JM AA. Rats
subjected to cortical infarction show greater vascular hy-
pertrophy and AR dysfunction and reduced endothelium-
dependent vasodilation ability than rats subjected to surgi-
cal excision. Differences in the severity and progression of
glomerular sclerosis have been reported between these two
models of CRF, with slower progression and less severe
hypertension in the surgical excision model [9].
The most important finding in our study is that acute
exposure to IGF-I at least partially restores AR ability in
AA from CRF rats. In addition, whereas IGF-I vasodilates
normal kidneys, it vasoconstricts JM AA from rats with
CRF at pressures at or above normotensive levels. These
studies offer no insight into the mechanism of IGF-I action
in CRF. However, studies in normal rats have implicated
Fig. 3. Responses to topical application of 10 mM acetylcholine in mid-
afferent arterioles (AA) segments from rats with five-sixths nephrectomy
via surgical excision or cortical infarction and in sham controls. The
responses in the infarction group were significantly smaller than in the other
two groups (P , 0.05, analysis of variance and Student-Newman-Keuls test).
Fig. 2. Autoregulation responses in mid-afferent arterioles (AA) segments from rats subjected to five-sixths nephrectomy by surgical excision (N 5
7), cortical infarction (N 5 5), or control sham surgery (N 5 6). Shown are baseline responses (F) and responses during treatment with 10 nM
insulin-like growth factor-I (IGF-I; E) or 10 mM MnCl2 to block calcium channels (f). Autoregulation in both chronic renal failure (CRF) groups was
significantly impaired versus the sham controls [P , 0.05, two-way analysis of variance (ANOVA)] and was significantly enhanced by IGF-I in both CRF
groups (P , 0.05, two-way repeated measures ANOVA).
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both NO and vasodilatory prostanoids [5], and studies in
cultured endothelial cells show that IGF-I stimulates endo-
thelin release [12]. We have recently reported evidence
consistent with the participation of all three agents [13].
Nevertheless, our studies suggest that IGF-I treatment may
be able slow the progression of CRF by restoring some
degree of AR control of glomerular capillary pressure and
flow. Further study is required to evaluate this interesting
possibility.
ACKNOWLEDGMENTS
Recombinant human IGF-I was supplied by Genentech, Inc. B. To¨n-
shoff and N. Bouriquet were recipients of Fellowships from the New York
State Affiliate of the American Heart Association. J.-J. Lin was a recipient
of a Fellowship from the National Kidney Foundation of New York/New
Jersey.
APPENDIX
Abbreviations used in this article are: AA, afferent arterioles; ANOVA,
analysis of variance; AR, autoregulation; CRF, chronic renal failure;
IGF-I, insulin-like growth factor-I; JM, juxtamedullary; KBR, Krebs-
bicarbonate-Ringer; NO, nitric oxide; Nx, nephrectomy; RM, repeated
measures.
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